| Cell line name |
T-289 |
| Synonyms |
289 |
| Accession |
CVCL_8760 |
| Resource Identification Initiative |
To cite this cell line use: T-289 (RRID:CVCL_8760) |
| Comments |
Characteristics: Established from a xenograft maintained in nude mice. |
| Disease |
Melanoma (NCIt: C3224) |
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
| Hierarchy |
Children:
|
| Sex of cell |
Sex unspecified |
| Age at sampling |
Age unspecified |
| Category |
Cancer cell line |
| Publications | PubMed=3652009; DOI=10.1002/1097-0142(19871015)60:8<1836::AID-CNCR2820600827>3.0.CO;2-O Raymond Taetle, Oliver W. Jones, J. Michael Honeysett, Ian Abramson, Christy Bradshaw, Steven Reid; Use of nude mouse xenografts as preclinical screens. Characterization of xenograft-derived melanoma cell lines. Cancer 60:1836-1841(1987) PubMed=8752169 Edward F. McClay, Jeffrey A. Jones, Paul J. Winski, Kathleen D. Albright, Randolph D. Christen, Stephen B. Howell; Determinants of tamoxifen sensitivity control the nature of the synergistic interaction between tamoxifen and cisplatin. Cancer Res. 56:3993-3997(1996) PubMed=9205073 Jeffrey A. Jones, Kathleen D. Albright, Randolph D. Christen, Stephen B. Howell, Edward F. McClay; Synergy between tamoxifen and cisplatin in human melanoma cells is dependent on the presence of antiestrogen-binding sites. Cancer Res. 57:2657-2660(1997) PubMed=10661763; DOI=10.1097/00008390-199912000-00001 Edward F. McClay, Jeffrey A. Jones; Characterization of a human melanoma cell line with non-oestrogen receptor dependent tamoxifen resistance. Melanoma Res. 9:531-537(1999) |
| Cross-references |
| Anatomy/cell type resources |
BTO; BTO_0004618
|
| Encyclopedic resources |
Wikidata; Q54971335
|
| Entry history |
| Entry creation | 04-Apr-2012 |
| Last entry update | 19-Dec-2024 |
| Version number | 10 |
|---|